These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 2137266

  • 1. Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator.
    Edelberg JM, Gonzalez-Gronow M, Pizzo SV.
    Thromb Res; 1990 Jan 01; 57(1):155-62. PubMed ID: 2137266
    [No Abstract] [Full Text] [Related]

  • 2. Lipoprotein(a) inhibits plasminogen activation in a template-dependent manner.
    Edelberg JM, Pizzo SV.
    Blood Coagul Fibrinolysis; 1991 Dec 01; 2(6):759-64. PubMed ID: 1839224
    [Abstract] [Full Text] [Related]

  • 3. Lipoprotein(a), fibrin binding, and plasminogen activation.
    Loscalzo J, Weinfeld M, Fless GM, Scanu AM.
    Arteriosclerosis; 1990 Dec 01; 10(2):240-5. PubMed ID: 2138452
    [Abstract] [Full Text] [Related]

  • 4. The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activation.
    Liang JF, Li Y, Yang VC.
    Thromb Res; 2000 Mar 01; 97(5):349-58. PubMed ID: 10709911
    [Abstract] [Full Text] [Related]

  • 5. Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein.
    Simon DI, Fless GM, Scanu AM, Loscalzo J.
    Biochemistry; 1991 Jul 09; 30(27):6671-7. PubMed ID: 1829635
    [Abstract] [Full Text] [Related]

  • 6. Absence of inhibition by lipoprotein (a) inhibition of tPA induced thrombolysis in a patient's plasma milieu.
    Lu H, Bruckert J, Soria J, Li H, de Gennes JL, Legrand A, Peynet J, Soria C.
    Blood Coagul Fibrinolysis; 1990 Oct 09; 1(4-5):513-6. PubMed ID: 1966796
    [Abstract] [Full Text] [Related]

  • 7. Kinetic analysis of the effects of heparin and lipoproteins on tissue plasminogen activator mediated plasminogen activation.
    Edelberg JM, Pizzo SV.
    Biochemistry; 1990 Jun 26; 29(25):5906-11. PubMed ID: 2143417
    [Abstract] [Full Text] [Related]

  • 8. Euglobulin clot lysis induced by tissue-type plasminogen activator is reduced in subjects with increased levels of lipoprotein (a).
    Aznar J, Estellés A, Bretó M, España F, Alós T.
    Thromb Res; 1992 Jun 01; 66(5):569-82. PubMed ID: 1387993
    [Abstract] [Full Text] [Related]

  • 9. Effect of lipoprotein(a) and LDL on plasminogen binding to extracellular matrix and on matrix-dependent plasminogen activation by tissue plasminogen activator.
    Pekelharing HL, Kleinveld HA, Duif PF, Bouma BN, van Rijn HJ.
    Thromb Haemost; 1996 Mar 01; 75(3):497-502. PubMed ID: 8701415
    [Abstract] [Full Text] [Related]

  • 10. Lipoprotein(a) in heart disease.
    Lawn RM.
    Sci Am; 1992 Jun 01; 266(6):54-60. PubMed ID: 1533952
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization of the murine plasma fibrinolytic system.
    Lijnen HR, van Hoef B, Beelen V, Collen D.
    Eur J Biochem; 1994 Sep 15; 224(3):863-71. PubMed ID: 7523120
    [Abstract] [Full Text] [Related]

  • 13. Lipoprotein(a): a kinetic study of its influence on fibrin-dependent plasminogen activation by prourokinase or tissue plasminogen activator.
    Liu JN, Harpel PC, Pannell R, Gurewich V.
    Biochemistry; 1993 Sep 21; 32(37):9694-700. PubMed ID: 8373773
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Euglobulin clot lysis induced by tissue type plasminogen activator in subjects with increased levels and different isoforms of lipoprotein (a).
    Aznar J, Estellés A, Bretó M, España F.
    Thromb Res; 1993 Dec 01; 72(5):459-65. PubMed ID: 8303689
    [No Abstract] [Full Text] [Related]

  • 16. Lp(a): an interloper into the fibrinolytic system?
    Miles LA, Plow EF.
    Thromb Haemost; 1990 Jun 28; 63(3):331-5. PubMed ID: 2169655
    [No Abstract] [Full Text] [Related]

  • 17. Molecular interactions between tissue-type plasminogen activator and plasminogen.
    Lijnen HR, Collen D.
    Methods Enzymol; 1993 Jun 28; 223():197-206. PubMed ID: 8271953
    [No Abstract] [Full Text] [Related]

  • 18. Fibrinogen alpha C domains contain cryptic plasminogen and tPA binding sites.
    Tsurupa G, Medved L.
    Ann N Y Acad Sci; 2001 Jun 28; 936():328-30. PubMed ID: 11460488
    [Abstract] [Full Text] [Related]

  • 19. A potential basis for the thrombotic risks associated with lipoprotein(a).
    Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF.
    Nature; 1989 May 25; 339(6222):301-3. PubMed ID: 2542796
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.